Wijsenbeek MS, Floricel F, Thonnard J, et al. A worldwide review of ‘real’ life’ practice: experience from a treatment feasibility review in 41 countries. ERS 2018, Parijs. Sessie 46; OA263.
MUC5B-promotervariant rs35705950 risicofactor voor RA-geassocieerde ILD
feb 2019 | ILD, Pneumonie, RA